Medesis Pharma S.A. (ALMDP.PA)
EUR 0.34
(-2.86%)
EUR 0.34
(-2.86%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 300.03 Thousand | 47.29 Thousand | 95.72 Thousand | 208.5 Thousand | 230 Thousand | 11 Thousand |
| Cost of Revenue | 2.96 Million | 2.25 Million | 2.26 Million | 705.68 Thousand | 370 Thousand | 364 Thousand |
| Gross Profit | -2.66 Million | -2.2 Million | -2.17 Million | -497.18 Thousand | -140 Thousand | -353 Thousand |
| Operating Expenses | 1.56 Million | 1.03 Million | 1.04 Million | 490.7 Thousand | 651 Thousand | 849 Thousand |
| Selling, General and Administrative Expenses | 1.24 Million | 1.02 Million | 2.24 Million | 678.85 Thousand | 364 Thousand | 359 Thousand |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 319.58 Thousand | 1.03 Million | -1.2 Million | -188.15 Thousand | 287 Thousand | 490 Thousand |
| Cost and Expenses | 4.52 Million | 3.29 Million | 3.31 Million | 1.19 Million | 1.02 Million | 1.21 Million |
| Operating Income | -4.22 Million | -3.24 Million | -3.21 Million | -987.89 Thousand | -789 Thousand | -1.2 Million |
| Interest Expense | 254.85 Thousand | 72.91 Thousand | 9424.00 | 67.23 Thousand | 442 Thousand | 41 Thousand |
| Income Tax Expense | -436.23 Thousand | -479.6 Thousand | -563.75 Thousand | -199.4 Thousand | -152 Thousand | -215 Thousand |
| Earnings before Tax | -4.39 Million | -3.24 Million | -3.21 Million | -1.04 Million | -1.23 Million | -1.24 Million |
| Net Income | -3.95 Million | -2.76 Million | -2.64 Million | -847.08 Thousand | -1.07 Million | -1.02 Million |
| Earnings Per Share Basic | -0.80 | -0.63 | -0.61 | -0.26 | -0.36 | -0.24 |
| Earnings Per Share Diluted | -0.80 | -0.63 | -0.61 | -0.26 | -0.36 | -0.24 |
| Weighted Average Shares Outstanding | 4.96 Million | 4.39 Million | 4.36 Million | 3.26 Million | 3 Million | 4.21 Million |
| Weighted Average Shares Outstanding (Diluted) | 4.96 Million | 4.39 Million | 4.36 Million | 3.26 Million | 3 Million | 4.21 Million |
| Gross Margin | -8.88 | -46.62 | -22.67 | -2.38 | -0.61 | -32.09 |
| EBIT Margin | -12.81 | -64.87 | -31.84 | -4.25 | -2.70 | -75.91 |
| Profit Margin | -13.20 | -58.42 | -27.67 | -4.06 | -4.69 | -92.91 |
| EBITDA | -3.84 Million | -3.05 Million | -3.04 Million | -894.97 Thousand | -622 Thousand | -835 Thousand |
| Earnings Before Tax Margin | -14.10 | -68.58 | -33.58 | -4.74 | -3.43 | -109.18 |
| Breakdown | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Revenue | 300.03 Thousand | 16.24 Thousand | 16.24 Thousand | 133.77 Thousand | 133.77 Thousand | 47.29 Thousand |
| Cost of Revenue | 2.96 Million | 877.78 Thousand | 877.78 Thousand | 604.61 Thousand | 604.61 Thousand | 2.25 Million |
| Gross Profit | -2.66 Million | -861.54 Thousand | -861.54 Thousand | -470.84 Thousand | -470.84 Thousand | -2.2 Million |
| Operating Expenses | 1.56 Million | 413.88 Thousand | 413.88 Thousand | 368.4 Thousand | 372.79 Thousand | 1.03 Million |
| Selling, General and Administrative Expenses | - | 334.57 Thousand | 334.57 Thousand | 287.92 Thousand | 287.92 Thousand | - |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | 79.3 Thousand | 79.3 Thousand | 80.48 Thousand | - | 1.03 Million |
| Cost and Expenses | 4.52 Million | 1.29 Million | 1.29 Million | 973.02 Thousand | 977.4 Thousand | 3.29 Million |
| Operating Income | -4.22 Million | -1.27 Million | -1.27 Million | -839.24 Thousand | -839.24 Thousand | -3.24 Million |
| Interest Expense | 254.85 Thousand | - | - | - | - | 72.91 Thousand |
| Income Tax Expense | -436.23 Thousand | 115.64 Thousand | 115.64 Thousand | 102.47 Thousand | 102.47 Thousand | -479.6 Thousand |
| Earnings before Tax | -4.39 Million | -1.28 Million | -1.28 Million | -910.5 Thousand | -910.5 Thousand | -3.24 Million |
| Net Income | -3.95 Million | -1.17 Million | -1.17 Million | -808.03 Thousand | -808.03 Thousand | -2.76 Million |
| Earnings Per Share Basic | - | -0.24 | -0.24 | -0.18 | -0.18 | - |
| Earnings Per Share Diluted | - | -0.24 | -0.24 | -0.18 | -0.18 | - |
| Weighted Average Shares Outstanding | 4.42 Million | 4.96 Million | 4.96 Million | 4.42 Million | 4.42 Million | 4.39 Million |
| Weighted Average Shares Outstanding (Diluted) | 4.42 Million | 4.96 Million | 4.96 Million | 4.42 Million | 4.42 Million | 4.39 Million |
| Gross Margin | -8.88 | -53.04 | -53.04 | -3.52 | -3.52 | -46.62 |
| EBIT Margin | - | -73.90 | -73.90 | -5.73 | -5.73 | - |
| Profit Margin | -13.20 | -72.14 | -72.14 | -6.04 | -6.04 | -58.42 |
| EBITDA | - | -1.2 Million | -1.2 Million | -766.34 Thousand | -766.34 Thousand | - |
| Earnings Before Tax Margin | -14.10 | -78.52 | -78.52 | -6.27 | -6.27 | -68.58 |
BALD-B
IMUC
PSHG
2490
300080
GSL-PB